期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性髓细胞白血病的染色体研究进展 被引量：2

原文传递
导出
摘要 急性髓细胞白血病（AML）是造血干细胞获得性突变所致的恶性克隆性疾病。细胞遗传学分析可以揭示作为恶性克隆标记的染色体畸变，目前已成为AML诊断分型和预后评估中不可或缺的重要工具。近来随着观察的深入和新技术的应用，AML的染色体研究又取得了不少进展。
作者 薛永权
机构地区 苏州大学附属第一医院、江苏省血液研究所
出处 《国际输血及血液学杂志》 CAS 2007年第3期193-197,共5页 International Journal of Blood Transfusion and Hematology
关键词 急性髓细胞白血病 染色体畸变 恶性克隆性疾病 细胞遗传学分析 造血干细胞 预后评估 诊断分型 AML
分类号 R733 [医药卫生—肿瘤]
  • 相关文献

参考文献30

  • 1Frohling S, Scholl C, Gilliland G, et al. Genetics of myeloid malignancies : pathogenetic and clinical implications. J Clin Oncol, 2005,23(26) :6285-6295.
  • 2Zhang FF, Murata-collins JL, Gaytan P, et al. Twenty-fourcolor Spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia. Genes Chromosomes Cancer,2000,28(3) :318-328.
  • 3Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Roy,2004, 18(2) : 115-136.
  • 4Harris NL, Jaffe ES, Dieblod J, et al. World health organization classification of neoplastic disease of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol, 1999,17(2) : 3835-3849.
  • 5Meyer C, Schneider B, Reichel M, et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. PNAS,2005,102(2) :449-454.
  • 6Shih L-Y, Liang D-C,Fu J F, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia ,2006,20(2) : 218-223.
  • 7Romana SP, Radford-Weiss I, Abdelali RB, et al. NUP98 rearrangements in hematopoietie malignancies: a study of the Groupe Francophome de cytogenetique Hematologique. Leukemia, 2006,20(4) : 696-706.
  • 8Hromas R, Shopnik R, George H, et al. A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood,2000,95(12) :4011-4013.
  • 9Gilliland DG. Hematologic malignancies. Current Opinions in Haematology, 2001,8(4) :189-191.
  • 10Reilly JT. Pathogenesis of acute myeloid leukemia and inv(16) (p13q22): a paradigm for understanding leukemogenesis? Br J Haematol, 2004,128 ( 1 ) : 18- 34.

二级参考文献5

  • 1Yan M,Burel SA,Peterson LF,et al.Deletion of an AML1-ETO Cterminal NcoRSMRT-interacting region strongly induces leukemia development.Proc Natl Acad Sci U S A,2004,101:17186-17191.
  • 2Wolford JK,Prochazka M.Structure and expression of the human MTG8/ETO gene.Gene,1998,212:103-109.
  • 3Miyamoto TK,Nagafuji K,Akashi M,et al.Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t (8; 21) acute myelogenous leukemia.Blood,1996,87:4789-4796.
  • 4王敏,王玲,郝长来,邢海燕,唐克晶,王建祥.ETO转录抑制结构域的分析与鉴定[J].中华血液学杂志,2003,24(1):10-13. 被引量：3
  • 5潘勤,陈赛娟.ETO在白血病发病机制中的研究进展[J].国外医学（遗传学分册）,2004,27(2):85-89. 被引量：4

共引文献4

同被引文献39

  • 1崔久嵬,王冠军,李薇,王杰,张学敏.急性白血病细胞与正常白细胞差异蛋白质组分析[J].中国实验血液学杂志,2006,14(2):201-207. 被引量：5
  • 2张军,王惠芳,张建中,马一盖,王建文.蛋白芯片技术筛选急性髓性白血病血清标志蛋白质[J].军医进修学院学报,2006,27(5):355-357. 被引量：2
  • 3陈苏宁（综述）,吴德沛（审校）,薛永权（审校）.急性髓细胞白血病的分子遗传学研究进展[J].国际输血及血液学杂志,2007,30(3):222-226. 被引量：1
  • 4Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia[J]. Blood Rev,2004,18(2) :115-136.
  • 5Bullinger L, Valk PJ. Gene expression profiling in acute myeloid leukemia[ J ]. J Clin Oncol,2005,23 (26) :6296-6305.
  • 6Chi Y,Lindgren V, Quigley S, et al. Acute myelogenous leukemia with t (6 ; 9 ) ( p23 ; q34 ) and marrow basophilia : an overview [ J ]. Arch Pathol Lab Med,2008,132 ( 11 ) : 1835-1837.
  • 7Sehlenk RF, Benner A, Krauter J, et al. Individual patient databased met.a-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup [ J ]. J Clin Oncol, 2004,22 ( 18 ) : 3741-3750.
  • 8Wang YY,Zhou GB,Yin T,et al. AML1-ETO and C-KIT mutation/overexpression in t ( 8 ; 21 ) leukemia: implication in stepwise leukemogenesis and response to Gleevec [ J ]. Proe Natl Acad SciU S A,2005,102(4):1104-1109.
  • 9Schnittger S, Kohl TM, Haferlach T, et al. KIT-D816 mutations in AML1/ETO-positive AML are associated with impaired event-free and overall survival [ J ]. Blood,2006,107 (5) : 1791-1799.
  • 10Cairoli R, Beghini A, Grillo G, et al. Prognostic impact of e-KIT mutations in core binding factor leukemias:an Italian retrospective study [ J ]. Blood,2006,107 (9) :3463-3468.

引证文献2

二级引证文献6

国际输血及血液学杂志
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部